1137-P: Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-Term Testosterone Therapy for Up to 12 Years in a Real-Life Registry Study

KARIM S. HAIDER; AHMAD HAIDER; FARID SAAD

doi:10.2337/db19-1137-p

1137-P: Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-Term Testosterone Therapy for Up to 12 Years in a Real-Life Registry Study

Diabetes ◽

10.2337/db19-1137-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1137-P

Author(s):

KARIM S. HAIDER ◽

AHMAD HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

105 Improvement of Type 2 Diabetes (T2DM) in Hypogonadal Men receiving Long-term Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2017.11.063 ◽

2018 ◽

Vol 15 (2) ◽

pp. S21-S22

Author(s):

F. Saad ◽

K. Haider ◽

A. Haider

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

Remission of Type 2 Diabetes in 12% (16 of 133) Hypogonadal Men Receiving Long-Term Testosterone Therapy in a Real-Life Registry Study

Diabetes ◽

10.2337/db18-125-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 125-OR

Author(s):

AHMAD HAIDER ◽

KARIM S. HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

375 Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-term Testosterone Therapy for up to 12 Years in a Real-life Registry Study

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2019.11.220 ◽

2020 ◽

Vol 17 (1) ◽

pp. S104

Author(s):

K.S. Haider ◽

A. Haider

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

Improvement of Type 2 Diabetes (T2DM) and Reduction of Major Adverse Cardiovascular Events and Mortality in Hypogonadal Men Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU)—Real-Life Evidence from a Urological Registry Study

Diabetes ◽

10.2337/db18-111-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 111-LB

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Events ◽

Real Life ◽

Term Treatment ◽

Major Adverse Cardiovascular Events ◽

Registry Study ◽

Testosterone Undecanoate ◽

Long Term Treatment

Download Full-text

Long-term testosterone therapy improves glycaemic control and weight control in men with type 2 diabetes: 12-year observational data from a controlled registry study in a urological setting

Endocrine Abstracts ◽

10.1530/endoabs.73.oc2.3 ◽

2021 ◽

Author(s):

Farid Saad ◽

Karim Sultan Haider ◽

Ahmad Haider

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Observational Data ◽

Weight Control ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

Abstract #275: Effects of Long-Term Testosterone Undecanoate (TU) Therapy on Anthropometric Parameters in Hypogonadal Men with Type 2 Diabetes (T2DM): Real-Life Data from a Registry Study

Endocrine Practice ◽

10.1016/s1530-891x(20)44983-3 ◽

2016 ◽

Vol 22 ◽

pp. 70

Author(s):

Farid Saad ◽

Ahmad Haider ◽

Karim Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Anthropometric Parameters ◽

Testosterone Undecanoate ◽

Life Data ◽

Real Life Data

Download Full-text

1057-P: Long-Term Testosterone Therapy Results in Remission of Type 2 Diabetes (T2DM) in 34.3% (61 of 178) Men with Hypogonadism and T2DM in a Real-World Registry Study

Diabetes ◽

10.2337/db20-1057-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 1057-P

Author(s):

KARIM S. HAIDER ◽

AHMAD HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

PD45-06 LONG-TERM EFFECTS ON ERECTILE FUNCTION UPON TREATMENT UP TO 11 YEARS WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM): REAL-LIFE DATA FROM AN OBSERVATIONAL REGISTRY STUDY

The Journal of Urology ◽

10.1016/j.juro.2015.02.2578 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Aksam Yassin ◽

Yousef Al Mehmadi

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Long Term Effects ◽

Testosterone Undecanoate ◽

Life Data ◽

Real Life Data

Download Full-text

Sustained Improvement of Obesity in Hypogonadal Men with Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU)—Real-Life Evidence from a Urological Registry Study

Diabetes ◽

10.2337/db18-300-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 300-LB

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Term Treatment ◽

Registry Study ◽

Testosterone Undecanoate ◽

Sustained Improvement ◽

Long Term Treatment

Download Full-text

099 Erectile function improves in hypogonadal men with type 2 diabetes under long-term testosterone therapy: real-world evidence from a urological registry study

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2018.04.102 ◽

2018 ◽

Vol 15 (7) ◽

pp. S169-S170

Author(s):

F. Saad ◽

K.S. Haider ◽

G. Doros ◽

A. Traish ◽

A. Haider

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Erectile Function ◽

Registry Study ◽

Testosterone Therapy ◽

Real World Evidence

Download Full-text